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Edited by Ivan SadowskiAbstract The 26S proteasome is a multi-subunit protease com-
plex and plays an essential role in many basic cellular processes.
The abundance of the 26S proteasome is controlled by a negative
feedback circuit that involves the Rpn4p transcriptional activa-
tor. To date, the functional regions of Rpn4p are largely un-
known. We mapped the Rpn4p transactivation domains by
deletion analysis. The distal acidic domain has stronger transac-
tivation potential than that of the proximal acidic domain. How-
ever, the N-terminal region, and not the acidic domains of
Rpn4p, is crucial for Rpn4p function. Within the N-terminus,
we mapped a novel transactivation domain, which may be regu-
lated by some modiﬁcation of lysines in a proteolysis-indepen-
dent manner.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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domains1. Introduction
The ubiquitin–proteasome system plays an essential role in
the degradation of intracellular proteins and regulation of
many basic cellular processes. This system tags certain proteins
with polyubiquitin chains, leading to subsequent recognition
and degradation by the 26S proteasome [1 and references there-
in]. While the structure and mechanistic aspects of protea-
somes are currently fairly well understood, much less is
known regarding the regulation of proteasomal genes. The
best characterized system for this type of regulation has been
found in Saccharomyces cerevisiae [2,3], and consists of a tran-
scription factor, Rpn4p, and its binding site, PACE (protea-
some associated control element).
The role of Rpn4p in the regulation of proteasomal genes
was ﬁrst established in our previous study of a model system
utilizing the promoters of proteasomal genes from the RPT
(Regulatory Particle ATPase) group linked to the cat reporter
bacterial gene [2]. The data from this study were later corrob-
orated in other studies [4,5] and [6]. Rpn4p was characterized
and found to be a proteasomal subunit [7], however, some
authors have not detected Rpn4p in proteasome preparationsAbbreviations: CAD, C-terminal acidic domain; NAD, N-terminal
acidic domain; NTAD, N-terminal transactivation domain; MMS,
methyl-4-methanesulfonate
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doi:10.1016/j.febslet.2008.09.010[8,9]. It transpired that Rpn4p is an extremely short-lived pro-
teasomal substrate and may be degraded by both ubiquitin-
dependent and -independent mechanisms [4,10]. Taken
together, these data suggest that proteasome abundance is
regulated by a negative feedback circuit.
In addition to regulating proteasomal genes, Rpn4p presum-
ably regulates the expression of many other genes [3,11,12] and
[13], and several of these are involved in stress responses.
Accordingly, it has been shown that Rpn4p plays an important
role in cellular resistance to variable stresses [5,6,14–16]. Since
RPN4 is a Pdr1p/Pdr3p target, it may also be involved in mul-
tidrug resistance [16].
In order to learn more about the function of Rpn4p as a
transcriptional activator, we mapped its transactivation do-
mains by deletion analysis. We found that the acidic domains
have diﬀerent transactivation potentials. In this paper, we de-
scribe a novel transactivation domain that was mapped to the
N-terminus between residues 109 and 151. This domain does
not contain any features that are common to known classes
of activation domains. This region contains four lysines, which
serve as alternative ubiquitination sites, but play a minor role
in Rpn4p degradation [17]. Substitution of these lysines with
arginines upregulates Rpn4p activity and does not aﬀect the
expression level of Rpn4p. These results suggest that proteoly-
sis-independent modiﬁcation of these lysines may be involved
in the regulation of Rpn4p activity.2. Materials and methods
We used the following yeast strains: 334t (MATa, pep4-3, prb1-
1122, ura3-52, leu2-3,112, reg1-501, gal1) and rpn4-D (an rpn4::G418
derivative of 334t). Details of the plasmid constructs used are available
upon request. The RPN4 deletion derivatives were generated by PCR-
mediated mutagenesis and conﬁrmed by DNA sequencing. RPN4 and
its derivatives were cloned under the control of the GAL1 promoter in
the 2l pPDX2 vector (courtesy of S.V. Benevolensky) or the native
RPN4 promoter in the 2l pRS426 vector. Mutant proteins were ex-
pressed in the rpn4-D yeast strain. Yeast transformants were obtained
as previously described in [18].2.1. Reverse transcription-PCR (RT-PCR)
Total RNA was extracted as previously described [19]. RNA quality
was conﬁrmed by agarose-formaldehyde gel electrophoresis. The RNA
preparations were checked by PCR in order to conﬁrm that genomic
DNA was absent from the preparations. One microgram of total
RNA was used for cDNA synthesis with the RevertAid H-Minus kit
(Fermentas, Lithuania), according to the manufacturers instructions.
The ampliﬁcation mixtures for real-time PCR were prepared using a
SYBR Green containing kit (Syntol, Russia), according to the manu-
facturers instructions. Each reaction contained cDNA (equivalent to
50 ng of reverse-transcribed RNA) and 500 nM of primers. The se-
quences of the primers are available upon request. Reactions wereblished by Elsevier B.V. All rights reserved.
Fig. 1. Dissection of Rpn4p acidic domains. (A) Design of deletions. (B) Activity of mutant proteins. Relative mRNA levels of proteasomal genes in
yeast transformants expressing Rpn4p deletion derivatives. The mRNA levels were determined by RT-PCR as described in the methods section. The
reference gene is PDA1; its gene expression is not aﬀected by Rpn4p [16]. The relative mRNA levels of the proteasomal genes were normalized to
those in the rpn4-D strain, which were arbitrarily set to 1. The S.D. from the mean is shown. In each case cDNAs obtained from two independent
cultures were analyzed. (C) Expression of Rpn4p deletion derivatives. Yeast cell lysates were analyzed by Western blotting as described in Section 2.
Recombinant Rpn4p expressed in Escherichia coli (lane 1) was used as a size marker. Staining of a-tubulin was used as a loading control. The asterisk
indicates a cross-reacting band.
Fig. 2. Role of Rpn4p domains in cellular resistance to methyl
methanesulfonate. Cells of wild-type, rpn4-D, and various rpn4-D
transformants expressing full-length Rpn4p and deletion derivatives
were grown overnight at 30 C. Overnight cultures were diluted to
OD600 = 1.0, and then tenfold serial dilutions were prepared. Subse-
quently, 3ll of each dilution was spotted onto agar plates with glucose
selective medium containing MMS, which were then incubated at
30 C for 3 days. No MMS was added to the control plate.
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ing to the manufacturers instructions. Homogeneity of the PCR prod-
ucts was assessed using melting curves and agarose gel electrophoresis.
The results were processed using the ANK-16 software (Syntol). Fur-
ther analysis of data was performed using Microsoft Excel software.
2.2. Western blotting
At 6 h after GAL1 expression induction, the yeast cells were lysed by
boiling in 5· protein sample buﬀer for 15 min. Lysates were clariﬁed by
centrifugation, and supernatants were analyzed by Western blotting
using aﬃnity-puriﬁed rabbit polyclonal antibodies against recombi-
nant Rpn4p (1:10000), and secondary anti-rabbit antibodies conju-
gated with Hrp (1:30000, Jackson Immuno Research laboratories,
West Grove, USA). Anti-Rpn4p antibodies were puriﬁed as described
in [20]. a-Tubulin was stained with a primary mouse monoclonal anti-
body (1:4000, Sigma) and a secondary anti-mouse antibody conjugated
with Hrp (1:10000, Jackson Immuno Research laboratories, West
Grove, USA), and served as a loading control.
2.3. Chromatin immunoprecipitation assay
A 10 ml yeast culture with OD600 = 1–1.5 was ﬁxed in 1% formalde-
hyde for 15 min at 30 C. The reaction was stopped by adding glycine
to the ﬁnal concentration of 125 mM. Cells were lysed by vortexing
with glass beads (Sigma) in 0.3 ml of buﬀer A (50 mM HEPES,
150 mM NaCl, 1% Triton X-100, 0.1% deoxycholate, 5% glycerin,
5 · PIC (Protein Inhibitor Cocktail, Sigma)). Then, the volume of ly-
sates was adjusted to 1.5 ml with buﬀer B (50 mM HEPES, 150 mM
NaCl, 1% Triton X-100, 0.1% SDS, 1 · PIC). Lysates were sonicated
with Bandelin Sonopuls HD2070 (Bandelin Electronic, Germany) for
30 s ﬁve times, followed by a 60-s pause on ice each time. This yielded
chromatin fragments with an average size of 0.5–0.6 kb. The superna-
tant was isolated by centrifugation and incubated with a polyclonal
anti-Rpn4p antibody (1:300) overnight at 4 C. An aliquot of 20 ll
Protein A Sepharose beads (Amersham Biosciences) was added, and
then the mixture was incubated for 3 h at 4 C. The immunoprecipi-
tates were washed stringently, and the recovered chromatin was treatedwith proteinase K, followed by a reaction to reverse the crosslink for
6 h at 65 C. Puriﬁed genomic DNA was then used as templates for
real-time PCR using primer sets of pRPT6-top (5 0-TAAAACTGTCA-
AAATGCGAGC-3 0)/pRPT6-bot (5 0-TGAATCACCACCACCA-
GAAC-3 0) to amplify a 0.4 kb RPT6 promoter region containing
PACE and of pPRE1-top (5 0-TTGACAGGTTCTCTATGATACT-
3 0)/pPRE1-bot (5 0-CTTGTAATTGGTGTTCAATATTCAC-3 0) to
amplify a 0.2 kb PRE1 promoter.3. Results
C-terminal acidic domain (CAD) is the stronger transactiva-
tion domain than N-terminal acidic domain (NAD). It is known
Fig. 3. DNA-binding activity of N-terminal Rpn4p derivatives in vivo. DNA obtained by ChIP assay (see Section 2) was analyzed by real-time PCR.
Signals were normalized to that of DNA recovered from rpn4-D strain without antibodies, which was arbitrarily set to 1. The S.D. from the mean is
shown.
Fig. 4. Characterization of N-terminal Rpn4p deletion derivatives. (A) Design of N-terminal deletions. (B) Activity of N-terminal Rpn4p deletion
derivatives. In each case a single cDNA preparation was used per strain. (C) Expression levels of mutant proteins as determined by Western blotting.
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Fig. 5. Activity of Rpn4p mutants expressed from the native RPN4
promoter. Relative mRNA levels of proteasomal gene RPT4 in yeast
transformants expressing Rpn4p deletion derivatives from native
RPN4 promoter. For each strain cDNAs obtained from three
independent cultures were analyzed.
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tion factors are rich in acidic amino acid residues [21]. The se-
quence of Rpn4p reveals that there are two acidic regions in
positions 211–229 (NAD) and 300–315 (CAD), and these
regions have been proposed to be transactivation domains.
This assumption was challenged by the results of complemen-
tation tests that showed that, when both acidic domains are
deleted, Rpn4p still retains some activity [7]. However, while
the authors of this work completely removed CAD, NAD
was only partially removed, so the remaining part of NAD
could account for the transactivation activity in the mutant
protein. Our experiments showed that, although the deletion
of a segment that included both acidic domains (DNCAD)
did decrease Rpn4p activity, it did not completely abolish it
(Fig. 1B), suggesting that there is another transactivation do-
main present in Rpn4p. Surprisingly, deletion of NAD did
not aﬀect Rpn4p activity, while deletion of CAD decreased
activity to the same degree as deletion of both of the acidic do-
mains (Fig. 1B). However, overexpression of DNAD Rpn4p
mutant may have compensated a compromised transactivation
activity. Therefore, we expressed DCAD and DNAD mutants
from the native RPN4 promoter. This experiment showed that,
while DCAD mutant was unable to activate transcription,
DNAD mutant retained some activity (Fig. 5). These data sug-
gest that transactivaton potential of CAD is stronger than that
of NAD.
The N-terminus of Rpn4p is required for resistance to cell
stress. Since Rpn4p is important for resistance to cell stress,Fig. 6. Substitution of lysine with arginine in NTAD upregulates Rpn4p ac
mutant derivative Rpn4p(4K-R). The mRNA levels of proteasomal genes re
obtained from three independent cultures were analyzed. (C) Expression leve
asterisk indicates a cross-reactive band, which serves as a loading control.we investigated the role of Rpn4p regions in cellular resistance
to the alkylating agent methyl-4-methanesulfonate (MMS) by
growing serial dilutions of the yeast cell culture on agar plates.
The background level of Rpn4p expression from the GAL1
promoter on glucose-containing media was suﬃcient to restore
cellular resistance to stress in rpn4-D (Fig. 2). This experiment
also showed that yeast transformants expressing deletion
derivatives of Rpn4p that were without acidic domains were
still resistant to stress, while transformants expressing Rpn4p
without its N-terminal region (DN210) were as sensitive totivity. (A) Positions of mutated lysines. (B) Activity of Rpn4p and its
lative to the reference gene, PDA1, are shown. For each strain cDNAs
ls of Rpn4p and Rpn4p(4K-R) as determined by Western blotting. The
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surements of activities in Rpn4p mutants (Fig. 1B) and indi-
cate that the N-terminus of Rpn4p contains another
transactivation domain.
DN210 Rpn4p mutant binds to promoters of proteasomal
genes in vivo. To show that Rpn4p N-terminal deletion deriv-
ative could still translocate into nucleus and bind to promoters
of proteasomal genes, we performed the chromatin immuno-
precipitation assay. This experiment demonstrated that
DN210 Rpn4p mutant was indeed capable of binding to pro-
moters of RPT6 and PRE1 (Fig. 3A). These results prove that
N-terminal deletion abolishes the transactivation function of
Rpn4p and does not interfere with the nuclear localization
or DNA-binding activity of Rpn4p.
Mapping of a N-terminal transactivation domain. To map the
transactivation domain within the N-terminus, we constructed
and analyzed a series of Rpn4p N-terminal mutants (Fig. 4).
This experiment demonstrated dramatic diﬀerences in activities
between mutant proteins with deletions of the ﬁrst 109
(DN109) and 151 residues (DN151) (Figs. 4B, and 5). However,
expression levels of these proteins were found to be equal
(Fig. 4C, lanes 5 and 6) and the chromatin immunoprecipita-
tion assay demonstrated that both of these mutants were capa-
ble of binding to promoters of proteasomal genes (Fig. 3B and
C); therefore, we concluded that the region between 109 and
151 amino acids contained a putative, N-terminal transactiva-
tion domain (NTAD).
Lysine to arginine substitution in the NTAD upregulates
Rpn4p activity. The N-terminal transactivation domain of
Rpn4p does not have any features that are characteristic of
the transactivation domains of known transcription factors.
We noticed that this region contained four lysines: K123,
K132, K137, and K141, which, though they are ubiquitinated,
play only a minor role in Rpn4p degradation [17]. We hypoth-
esized that modiﬁcation of these lysines might regulate Rpn4p
activity. In order to test our hypothesis, we substituted all four
lysines with arginines using site-directed mutagenesis and then
measured the activity of the mutant protein [Rpn4p(4K-R)]
(Fig. 6). This experiment demonstrated that the activity of
Rpn4p(4K-R) was about four times higher than the activity
of the native protein; however, the expression level of Rpn4p
was not changed signiﬁcantly.4. Discussion
We assumed that the DNA-binding activity of Rpn4p is pro-
vided by two Zn2+ ﬁnger domains present in its C-terminus
[2,22], therefore, we analyzed the central and N-terminal parts
of the protein to search for potential transactivation domains.
Our results indicated that transactivaton potential of CAD is
stronger than that of NAD. NAD was previously character-
ized as an Rpn4p degradation signal [17], and consistent with
this earlier study, deletion of NAD, but not CAD, enhances
the level of mutant Rpn4p (Fig. 1C). Therefore, NAD may
not only participate in transcription activation, but it also
mediates Rpn4p degradation, while CAD is involved only in
transcription activation. Interestingly, CAD is homologous
to a Ca2+-binding loop of the EF-hand domain [23], suggesting
that its transactivation potential may be regulated by the
intracellular levels of Ca2+. Ca2+ ions have been shown to be
involved in the downregulation of the ubiquitin–proteasomesystem in the calcineurin-dependent pathway of G2 cell-cycle
regulation [24].
We have found a novel transactivation domain of Rpn4p
that is crucial for the transactivation function residing within
the N-terminus of Rpn4p. We designated this domain as the
N-terminal transactivation domain (NTAD). However, the
N-terminal region of Rpn4p (residues 1–151) that comprise
this domain was found to be inactive when it was fused to
the DNA-binding domain of Gal4p [10]. These results indi-
cate that the NTAD only functions in the context of the
Rpn4 protein. A chimeric protein with a longer region of
Rpn4p containing the NAD (residues 1–229) exhibits trans-
activation activity [10]. Possible interpretation of these data
is that the NTAD is an essential part of a larger domain,
which also includes a segment situated between residues
151–211.
What are the determinants of NTAD activity? This region is
not enriched in acidic, proline, glutamine or asparagine resi-
dues, and clearly does not belong to one of these major classes
of activation domains. NTAD contains four lysines, and some
modiﬁcation of these residues may lead to downregulation of
Rpn4p activity. There are several kinds of modiﬁcations of ly-
sines such as sumoylation, acetylation, and methylation. To
date, it is not clear what kind of modiﬁcation regulates Rpn4p
activity.
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